The Promise of Personalized Medicine
The Promise of Personalized Medicine
Breaking Down Borders: What Global Healthcare Can Teach Us About Precision Medicine
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
From the NHS in England to healthcare systems across Europe, Asia, and the Middle East, the path to bringing precision medicine to patients looks different everywhere — but the barriers are more universal than you might think.
In this episode, Perry is joined by Dr. Iris Faull Fleischer, a physician and global health innovator with extensive experience launching diagnostic technologies across the US, Europe, Asia, and the Middle East. Iris brings a uniquely international perspective on what unifies healthcare systems worldwide and where they diverge, and she makes a compelling case for why true precision medicine is as much about people and process as it is about technology.
In this episode, you’ll hear about:
- Why precision medicine starts with seeing each patient as a unique individual and how modern technology makes that vision more actionable than ever
- How the path to adoption looks different across global markets, and why clinical demand must come before regulatory and reimbursement conversations
- The full stakeholder ecosystem required to bring a new test to patients and why missing even one piece of that puzzle can stop innovation in its tracks
- The case for starting with a focused patient indication rather than swinging for broad market coverage right out of the gate
- A real-world liquid biopsy pilot with NHS England that brought clinicians, diagnostic companies, and public payers together in a rare risk-sharing collaboration
- Why the most expensive drug is ultimately the one that doesn't work and how diagnostics reframe the entire cost conversation
Whether you're on the front lines of patient care or working behind the scenes to bring the next generation of diagnostics to market, Iris's global perspective is a reminder that innovation without access is just a great idea and that getting it to patients requires far more than a breakthrough technology.
—-------
Stay connected with our host, Perry Dimas, here on LinkedIn!
📧 Interested in joining our medical director advisory group? Email us at info@accessdx.com
🔗 Connect on LinkedIn: linkedin.com/company/accessdx